Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 20 |
| Dec 2025 | 0 | 15 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 22 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2021 Filed Nov 10, 2021 22:09 UTC |
HAWKINS JAMES BDirector
|
GrantCommon Stock | 9,479 | $1.48 | $14,028.92 |
DisclosureSEC source: 0000898432-21-000723 · form4.xml · nonDerivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,747 F1 · price: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 05, 2021 Filed Nov 10, 2021 22:09 UTC |
HAWKINS JAMES BDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 5,501 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-21-000723 · form4.xml · derivative · entry 7 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,713 Underlying: Common Stock · 5,501 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 05, 2021 Filed Nov 10, 2021 22:09 UTC |
HAWKINS JAMES BDirector
|
SaleCommon Stock | 5,501 | $38.25 | $210,413.25 |
DisclosureSEC source: 0000898432-21-000723 · form4.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F2 · price: This transaction was executed in multiple trades at prices ranging from $38.25 to $38.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2021 Filed Nov 10, 2021 22:09 UTC |
HAWKINS JAMES BDirector
|
GrantCommon Stock | 5,501 | $1.48 | $8,141.48 |
DisclosureSEC source: 0000898432-21-000723 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,769 F1 · price: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:29 UTC |
HAWKINS JAMES BDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 12,285 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · derivative · entry 9 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,214 Underlying: Common Stock · 12,285 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:29 UTC |
HAWKINS JAMES BDirector
|
SaleCommon Stock | 12,285 | $38.45 | $472,402.48 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 6 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F4 · price: This transaction was executed in multiple trades at prices ranging from $38.20 to $39.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:29 UTC |
HAWKINS JAMES BDirector
|
GrantCommon Stock | 12,285 | $1.48 | $18,181.80 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 5 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,553 F1 · price: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 15:29 UTC |
HAWKINS JAMES BDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 16,735 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · derivative · entry 8 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,499 Underlying: Common Stock · 16,735 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 15:29 UTC |
HAWKINS JAMES BDirector
|
SaleCommon Stock | 16,735 | $38.01 | $636,037.10 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 4 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F3 · price: This transaction was executed in multiple trades at prices ranging from $38.00 to 38.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 15:29 UTC |
HAWKINS JAMES BDirector
|
GrantCommon Stock | 16,735 | $1.48 | $24,767.80 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,003 F1 · price: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 15:32 UTC |
VUOTO ANTHONYDirector
|
SaleCommon Stock | 3,690 | $37.23 | $137,380.91 |
DisclosureSEC source: 0000898432-21-000713 · form4.xml · nonDerivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,836 F1 · price: This transaction was executed in multiple trades at prices ranging from $36.62 to 37.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 02, 2021 Filed Nov 5, 2021 15:29 UTC |
HAWKINS JAMES BDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 4,766 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · derivative · entry 7 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,234 Underlying: Common Stock · 4,766 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| November 02, 2021 Filed Nov 5, 2021 15:29 UTC |
HAWKINS JAMES BDirector
|
SaleCommon Stock | 4,766 | $38.01 | $181,166.62 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F2 · price: This transaction was executed in multiple trades at prices ranging from $38.00 to 38.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 02, 2021 Filed Nov 5, 2021 15:29 UTC |
HAWKINS JAMES BDirector
|
GrantCommon Stock | 4,766 | $1.48 | $7,053.68 |
DisclosureSEC source: 0000898432-21-000712 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,034 F1 · price: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 20:07 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $34.47 | $172,332.50 |
DisclosureSEC source: 0000898432-21-000655 · form4.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 886,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $34.05 to $35.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 20:07 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $35.17 | $175,868.50 |
DisclosureSEC source: 0000898432-21-000655 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 891,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.87 to $35.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 01:46 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $33.45 | $167,245.50 |
DisclosureSEC source: 0000898432-21-000640 · form4.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 896,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $33.32 to $33.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2021 Filed Sep 2, 2021 01:46 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $33.70 | $168,489.00 |
DisclosureSEC source: 0000898432-21-000640 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 901,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.33 to $34.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 24, 2021 Filed Aug 25, 2021 21:52 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $33.59 | $167,974.00 |
DisclosureSEC source: 0000898432-21-000612 · form4.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 906,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021 F3 · price: This transaction was executed in multiple trades at prices ranging from $33.29 to $34.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 21:52 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $33.74 | $168,712.00 |
DisclosureSEC source: 0000898432-21-000612 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 911,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021 F2 · price: This transaction was executed in multiple trades at prices ranging from $33.21 to $34.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 20, 2021 Filed Aug 20, 2021 20:51 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $33.33 | $166,653.00 |
DisclosureSEC source: 0001602030-21-000002 · form4.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 916,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $33.00 to $33.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:51 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $33.26 | $166,319.50 |
DisclosureSEC source: 0001602030-21-000002 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 921,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.01 to $33.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 22:21 UTC |
HAWKINS JAMES BDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 7,891 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · derivative · entry 9 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,891 shares Expires 2022-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 22:21 UTC |
HAWKINS JAMES BDirector
|
SaleCommon Stock | 7,891 | $35.20 | $277,725.32 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 6 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F4 · price: This transaction was executed in multiple trades at prices ranging from $34.85 to 35.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 11, 2021 Filed Aug 11, 2021 22:21 UTC |
HAWKINS JAMES BDirector
|
GrantCommon Stock | 7,891 | $1.29 | $10,145.46 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 5 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,159 F1 · price: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:21 UTC |
HAWKINS JAMES BDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · derivative · entry 8 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,891 Underlying: Common Stock · 5,000 shares Expires 2022-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:21 UTC |
HAWKINS JAMES BDirector
|
SaleCommon Stock | 5,000 | $35.72 | $178,619.50 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 4 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F3 · price: This transaction was executed in multiple trades at prices ranging from $35.30 to 36.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:21 UTC |
HAWKINS JAMES BDirector
|
GrantCommon Stock | 5,000 | $1.29 | $6,428.50 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,268 F1 · price: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 21:43 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $35.18 | $175,914.00 |
DisclosureSEC source: 0000898432-21-000600 · form4.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 926,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $34.87 to 35.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:21 UTC |
HAWKINS JAMES BDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 4,609 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · derivative · entry 7 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,891 Underlying: Common Stock · 4,609 shares Expires 2022-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:21 UTC |
HAWKINS JAMES BDirector
|
SaleCommon Stock | 4,609 | $35.83 | $165,125.26 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 F2 · price: This transaction was executed in multiple trades at prices ranging from $35.50 to 36.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:21 UTC |
HAWKINS JAMES BDirector
|
GrantCommon Stock | 4,609 | $1.29 | $5,925.79 |
DisclosureSEC source: 0000898432-21-000601 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,877 F1 · price: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 21:43 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $35.47 | $177,337.50 |
DisclosureSEC source: 0000898432-21-000600 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 931,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.11 to 36.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 04, 2021 Filed Aug 4, 2021 21:29 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $33.81 | $169,041.00 |
DisclosureSEC source: 0000898432-21-000594 · form4.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 936,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $33.67 to $34.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 21:29 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $33.93 | $169,657.50 |
DisclosureSEC source: 0000898432-21-000594 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 941,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.46 to $34.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 21:23 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0000898432-21-000593 · form4.xml · derivative · entry 3 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 10,000 shares, was granted on 9/29/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. F2 · derivative.expiration_date: This option, representing a right to purchase a total of 10,000 shares, was granted on 9/29/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 21:23 UTC |
ALLEN MONTY KDirector
|
SaleCommon Stock | 4,597 | $34.08 | $156,665.76 |
DisclosureSEC source: 0000898432-21-000593 · form4.xml · nonDerivative · entry 2 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,778 F1 · price: This transaction was executed in multiple trades at prices ranging from $34.00 to $34.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 21:23 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionCommon Stock | 5,000 | $7.10 | $35,500.00 |
DisclosureSEC source: 0000898432-21-000593 · form4.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 15:30 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $34.43 | $172,160.00 |
DisclosureSEC source: 0000898432-21-000586 · form4.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 946,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $33.66 to $34.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 15:30 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $34.68 | $173,390.00 |
DisclosureSEC source: 0000898432-21-000586 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 951,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.39 to $35.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| July 20, 2021 Filed Jul 21, 2021 22:06 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $34.03 | $170,150.00 |
DisclosureSEC source: 0000898432-21-000579 · form4.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 956,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $33.24 to $35.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:06 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $33.87 | $169,350.00 |
DisclosureSEC source: 0000898432-21-000579 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 961,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.39 to $34.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| July 16, 2021 Filed Jul 19, 2021 21:38 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 19,000 | $33.78 | $641,820.00 |
DisclosureSEC source: 0000898432-21-000577 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 966,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $32.90 to $35.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| July 09, 2021 Filed Jul 9, 2021 22:36 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 1,000 | $30.36 | $30,355.00 |
DisclosureSEC source: 0000898432-21-000565 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021 F2 · price: The shares for this transaction were all executed at $30.355. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 23:22 UTC |
Scott Christopher K.Chief Financ. & Op. Officer
|
GrantRestricted Stock Units · Derivative | 5,084 | $29.50 | $149,978.00 |
DisclosureSEC source: 0000898432-21-000567 · form4.xml · derivative · entry 1 Scott Christopher K. · CIK 0001613803 · Chief Financ. & Op. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,084 Underlying: Common Stock · 5,084 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in over four years in annual installments, each equal to 25% of the RSU Grant, with the first installment vesting twelve (12) months from the effective date, July 8, 2021, and the second, third and fourth installments vesting respectively 24, 36 and 48 months from the effective date, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in over four years in annual installments, each equal to 25% of the RSU Grant, with the first installment vesting twelve (12) months from the effective date, July 8, 2021, and the second, third and fourth installments vesting respectively 24, 36 and 48 months from the effective date, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| June 29, 2021 Filed Jun 29, 2021 22:15 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $28.18 | $140,892.50 |
DisclosureSEC source: 0000898432-21-000510 · form4.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $28.00 to $28.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 22:15 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 5,000 | $28.38 | $141,890.50 |
DisclosureSEC source: 0000898432-21-000510 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $28.25 to $28.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 26, 2021 Filed Jun 29, 2021 23:18 UTC |
HAWKINS JAMES BDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-21-000514 · form4.xml · derivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On June 26, 2019, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on June 26, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On June 26, 2019, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on June 26, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| June 26, 2021 Filed Jun 29, 2021 23:18 UTC |
HAWKINS JAMES BDirector
|
Exercise / conversionCommon Stock | 1,268 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000514 · form4.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 23, 2021 Filed Jun 23, 2021 23:13 UTC |
Susi Roger E.Director · President, CEO and Chairman · 10% owner
|
SaleCommon Stock | 3,907 | $27.82 | $108,702.12 |
DisclosureSEC source: 0000898432-21-000493 · form4.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. F4 · price: This transaction was executed in multiple trades at prices ranging from $27.51 to $28.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.